Reaction
Joint Space Narrowing reporting signals
As of the last recalculation, Joint Space Narrowing appears in 294 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is DIROXIMEL FUMARATE (PRR 61.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diroximel Fumarate | 10 | 61.5 | 61.5 |
| Sulfasalazine | 53 | 58.3 | 58.3 |
| Leflunomide | 65 | 56.2 | 56.2 |
| Desoximetasone | 12 | 46.4 | 46.5 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 3 | 23.8 | 23.8 |
| Sarilumab | 8 | 22.0 | 22.0 |
| Orlistat | 7 | 19.6 | 19.6 |